1

40% of Oncologists Support Tyrosine Kinase Inhibitor Safety

 News Discuss 
Recent survey revealed a significant concern - 40% of oncologists advocate for an improved safety profile in Tyrosine Kinase Inhibitors. https://mdforlives.com/blog/tyrosine-kinase-inhibitors/

Comments

    No HTML

    HTML is disabled


    Report Page

Who Upvoted this Story

Search

Published News